Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society
暂无分享,去创建一个
W. Chung | G. Hansmann | D. Cornfield | J. Feinstein | T. Kuehne | S. Archer | R. Barst | M. Friedberg | M. Earing | R. Deterding | K. Stenmark | B. Thébaud | D. Wessel | R. Keller | J. Raj | D. Ivy | B. Hanna | S. Abman | T. Humpl | R. Steinhorn | M. Mullen | I. Adatia | J. Fineman | T. Kulik | E. Rosenzweig | J. Kinsella | G. Mallory
[1] Fellowship Award. Section on Cardiology and Cardiac Surgery , 2016, Pediatric Clinical Practice Guidelines & Policies.
[2] C. Thomson,et al. Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[3] D. Tibboel,et al. Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update , 2010, Neonatology.
[4] Bibliographic Sources,et al. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report , 2017 .
[5] Y. Ville,et al. Prenatal prediction of pulmonary arterial hypertension in congenital diaphragmatic hernia , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[6] W. Border,et al. Elevated Tricuspid Regurgitant Velocity as a Marker for Pulmonary Hypertension in Children With Sickle Cell Disease: Less Prevalent and Predictive Than Previously Thought? , 2015, Journal of pediatric hematology/oncology.
[7] M. Gaboli,et al. Use of palivizumab in infants and young children with severe respiratory disease: A delphi study , 2014, Pediatric pulmonology.
[8] D. DeMaso,et al. Quality of life and parental adjustment in pediatric pulmonary hypertension. , 2014, Chest.
[9] C. Dennis,et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.
[10] R. Barst,et al. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). , 2014, The American journal of cardiology.
[11] R. Barst,et al. Exercise Testing in Children with Primary Pulmonary Hypertension , 2014, Pediatric Cardiology.
[12] Alejandro Torres,et al. Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension , 2013, Pulmonary circulation.
[13] K. McCoy,et al. Right heart catheterization measuring central hemodynamics in cystic fibrosis during exercise. , 2013, Respiratory medicine.
[14] M. Humbert,et al. Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.
[15] R. Arena,et al. Evaluating exercise capacity in patients with pulmonary arterial hypertension , 2013, Expert review of cardiovascular therapy.
[16] Jennifer A. Rama,et al. Lung transplantation for childhood diffuse lung disease , 2013, Pediatric pulmonology.
[17] C. Vizza,et al. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome. , 2013, International journal of cardiology.
[18] J. Feinstein,et al. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. , 2013, American journal of respiratory and critical care medicine.
[19] M. Fallon,et al. Pulmonary vascular complications of liver disease. , 2013, American journal of respiratory and critical care medicine.
[20] Deepak L. Bhatt,et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[21] Deepak L. Bhatt,et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[22] D. Ivy,et al. Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension , 2013, Pediatric pulmonology.
[23] S. Hernández-Díaz,et al. Nonsteroidal Antiinflammatory Drugs in Late Pregnancy and Persistent Pulmonary Hypertension of the Newborn , 2013, Pediatrics.
[24] N. Gotteiner,et al. Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia , 2012, Journal of Perinatology.
[25] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[26] J. Stockman,et al. A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease , 2013 .
[27] Candace Timpte,et al. The Genetic Information Nondiscrimination Act , 2013 .
[28] Dunbar D Ivy,et al. Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children. , 2012, The American journal of cardiology.
[29] N. Roubinian,et al. Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension. , 2012, Chest.
[30] M. Hallman,et al. Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. , 2012, The Journal of pediatrics.
[31] C. Broberg,et al. Does anticoagulation in Eisenmenger syndrome impact long-term survival? , 2012, Congenital heart disease.
[32] C. Blaisdell,et al. National Heart, Lung, and Blood Institute Workshop: Improving Outcomes for Pulmonary Vascular Disease , 2012, Circulation.
[33] B. Rodgers,et al. Permissive hypercapnia in the management of congenital diaphragmatic hernia: our institutional experience. , 2012, Journal of the American College of Surgeons.
[34] M. Gladwin,et al. Mortality in adults with sickle cell disease and pulmonary hypertension. , 2012, JAMA.
[35] N. Hills,et al. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. , 2012, The American journal of cardiology.
[36] R. Steinhorn,et al. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. , 2012, Clinics in perinatology.
[37] W. Carlo,et al. Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.
[38] Shing‐Jong Lin,et al. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[39] G. Raskob,et al. Clinical features of paediatric pulmonary hypertension: a registry study , 2012, The Lancet.
[40] D. Ivy,et al. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. , 2012, Congenital heart disease.
[41] R. Barst,et al. A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension , 2012, Circulation.
[42] J. Towbin,et al. Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease , 2012, Pediatrics.
[43] R. Barst,et al. Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.
[44] D. Ivy,et al. Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension , 2011, Pediatric Cardiology.
[45] M. Gomberg-Maitland,et al. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. , 2012, Chest.
[46] Edward Y Lee,et al. Children suspected of having pulmonary embolism: multidetector CT pulmonary angiography--thromboembolic risk factors and implications for appropriate use. , 2012, Radiology.
[47] J. Granton,et al. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus , 2011, European Respiratory Review.
[48] Edward Y Lee,et al. Pulmonary MDCT angiography: value of multiplanar reformatted images in detecting pulmonary embolism in children. , 2011, AJR. American journal of roentgenology.
[49] H. Hillege,et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. , 2011, European heart journal.
[50] Jeroen J. Bax,et al. Real-time three-dimensional echocardiography: segmental analysis of the right ventricle in patients with repaired tetralogy of fallot. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[51] E. Jaeggi,et al. Echocardiographic assessment of right ventricular volumes after surgical repair of tetralogy of Fallot: clinical validation of a new echocardiographic method. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[52] T. Kuehne,et al. Impact of Gender and Age on Cardiovascular Function Late After Repair of Tetralogy of Fallot: Percentiles Based on Cardiac Magnetic Resonance , 2011, Circulation. Cardiovascular imaging.
[53] T. Delhaas,et al. Pediatric Pulmonary Hypertension in the Netherlands: Epidemiology and Characterization During the Period 1991 to 2005 , 2011, Circulation.
[54] J. Voigt,et al. Different patterns of adaptation of the right ventricle to pressure overload: a comparison between pulmonary hypertension and pulmonary stenosis. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[55] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[56] J. Slaughter,et al. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation , 2011, Journal of Perinatology.
[57] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[58] R. Souza,et al. Schistosomiasis and pulmonary hypertension , 2011, Expert review of respiratory medicine.
[59] Shu-Chien Huang,et al. Alternative approach for selected severe pulmonary hypertension of congenital heart defect without initial correction--palliative surgical treatment. , 2011, International journal of cardiology.
[60] Dionne A. Graham,et al. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. , 2011, The American journal of cardiology.
[61] L. Jain,et al. Morbidity and mortality in late preterm infants with severe hypoxic respiratory failure on extra-corporeal membrane oxygenation. , 2011, The Journal of pediatrics.
[62] J. Coles,et al. Primary pulmonary vein stenosis: the impact of sutureless repair on survival. , 2011, The Journal of thoracic and cardiovascular surgery.
[63] M. Gladwin,et al. NT‐pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease , 2011, British journal of haematology.
[64] M. Gladwin,et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. , 2011, Blood.
[65] Chang Won Choi,et al. Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia , 2011, Neonatology.
[66] V. Salemi,et al. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.
[67] P. Stankiewicz,et al. Alveolar capillary dysplasia. , 2011, American journal of respiratory and critical care medicine.
[68] A. Raina,et al. Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension. , 2011, Chest.
[69] Stephanie L. Jones,et al. Clinical Practice Guideline: Polysomnography for Sleep-Disordered Breathing Prior to Tonsillectomy in Children , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[70] Z. Jing,et al. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. , 2011, American journal of respiratory and critical care medicine.
[71] J. Klinger. Tadalafil for the treatment of pulmonary arterial hypertension , 2011, Expert review of respiratory medicine.
[72] C. Huddleston,et al. First experience with a paracorporeal artificial lung in a small child with pulmonary hypertension. , 2011, The Journal of thoracic and cardiovascular surgery.
[73] B. Brundage,et al. Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] F. Lyall,et al. Pre‐operative sildenafil and pulmonary endothelial‐related complications following cardiopulmonary bypass: a randomised trial in children undergoing cardiac surgery * , 2011, Anaesthesia.
[75] Matthew S. Yong,et al. Outcomes of surgery for simple total anomalous pulmonary venous drainage in neonates. , 2011, The Annals of thoracic surgery.
[76] T. Lehnert,et al. Dose and image quality at CT pulmonary angiography—comparison of first and second generation dual-energy CT and 64-slice CT , 2011, European Radiology.
[77] E. Rosenzweig,et al. Ambrisentan for pulmonary arterial hypertension due to congenital heart disease. , 2011, The American journal of cardiology.
[78] J. Jung. Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey , 2011, Korean journal of pediatrics.
[79] D. Celermajer,et al. Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. , 2011, The Journal of pediatrics.
[80] S. Harikrishnan,et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011 , 2011, Pulmonary circulation.
[81] S. Harikrishnan,et al. Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011 , 2011, Pulmonary circulation.
[82] D. Ivy,et al. Connective Tissue Disease Presenting With Signs and Symptoms of Pulmonary Hypertension in Children , 2011, Pediatric Cardiology.
[83] P. Mistry,et al. Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy , 2011, Journal of Inherited Metabolic Disease.
[84] J. Rychik,et al. Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan Operation: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial , 2011, Circulation.
[85] N. Klein,et al. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment , 2011, European Respiratory Journal.
[86] D. Ivy,et al. Pulmonary arterial hypertension: a comparison between children and adults , 2011, European Respiratory Journal.
[87] J. Sandoval,et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension , 2011, European Respiratory Journal.
[88] J. Tobias. B-type Natriuretic Peptide: Diagnostic and Therapeutic Applications in Infants and Children , 2011, Journal of intensive care medicine.
[89] M. Karck,et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery , 2011, Clinical Research in Cardiology.
[90] M. Murata,et al. Quantitative analysis of right ventricular function in patients with pulmonary hypertension using three-dimensional echocardiography and a two-dimensional summation method compared to magnetic resonance imaging. , 2011, The American journal of cardiology.
[91] D. Rowitch,et al. NIH Consensus Development Conference Statement: Inhaled Nitric-Oxide Therapy for Premature Infants , 2011, Pediatrics.
[92] M. Gladwin,et al. Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia , 2011, Haematologica.
[93] T. Miyawaki,et al. Pharmacokinetics of bosentan in routinely treated Japanese pediatric patients with pulmonary arterial hypertension. , 2011, Drug metabolism and pharmacokinetics.
[94] C. Vosa,et al. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery. , 2011, Texas Heart Institute journal.
[95] G. Raskob,et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. , 2011, Chest.
[96] S. Langton-Hewer,et al. Management of pulmonary hypertension in Down syndrome , 2011, European Journal of Pediatrics.
[97] I. Schulze-Neick,et al. Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children , 2010, European Respiratory Journal.
[98] S. Erickson,et al. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease , 2010, Cardiology in the Young.
[99] C. Denton,et al. Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management , 2010, European Respiratory Review.
[100] D. Ivy,et al. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the magic registry , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[101] G. Butrous,et al. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease , 2010, Intensive Care Medicine.
[102] R. Barst,et al. Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. , 2010, The American journal of cardiology.
[103] J. Swiston,et al. HIV and pulmonary arterial hypertension: a systematic review , 2010, HIV medicine.
[104] M. Moss,et al. Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. , 2010, American journal of respiratory and critical care medicine.
[105] P. Rao,et al. Flap valved closure of ventricular septal defects with increased pulmonary vascular resistance. , 2010, Interactive cardiovascular and thoracic surgery.
[106] M. Hazinski,et al. Pediatric Basic and Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations , 2010, Pediatrics.
[107] W. Hop,et al. Risk Factors for Chronic Lung Disease and Mortality in Newborns with Congenital Diaphragmatic Hernia , 2010, Neonatology.
[108] S. Eaton,et al. Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus , 2010, Neonatology.
[109] M. Rosenthal,et al. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance , 2010, Archives of Disease in Childhood.
[110] B. Das. Plasma B-Type Natriuretic Peptides in Children With Cardiovascular Diseases , 2010, Pediatric Cardiology.
[111] D. Ivy,et al. Medical therapy for pediatric pulmonary arterial hypertension. , 2010, The Journal of pediatrics.
[112] A. Thompson,et al. Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension , 2010, American journal of hematology.
[113] A. Saxena,et al. Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. , 2010, Journal of cardiothoracic and vascular anesthesia.
[114] G. Stellin,et al. Scimitar Syndrome: A European Congenital Heart Surgeons Association (ECHSA) Multicentric Study , 2010, Circulation.
[115] B. McCrindle,et al. Living at an altitude adversely affects exercise capacity in Fontan patients , 2010, Cardiology in the Young.
[116] J. Neuhaus,et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. , 2010, American journal of respiratory and critical care medicine.
[117] M. Friedberg,et al. Imaging the right ventricle—current state of the art , 2010, Nature Reviews Cardiology.
[118] K. Hamilton,et al. Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[119] V. Puri,et al. Extracorporeal membrane oxygenation in pediatric lung transplantation. , 2010, The Journal of thoracic and cardiovascular surgery.
[120] A. Bush,et al. Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit , 2010, American heart journal.
[121] O. Stumper,et al. Sildenafil in the management of the failing Fontan circulation , 2010, Cardiology in the Young.
[122] G. Urcelay,et al. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension , 2010, Journal of Perinatology.
[123] G. Kim,et al. Review article DOI: 10.3345/kjp.2010.53.6.688 , 2010 .
[124] R. Barst,et al. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension. , 2010, The American journal of cardiology.
[125] C. Tinelli,et al. BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants. , 2010, Early human development.
[126] M. Maggiorini. Prevention and treatment of high-altitude pulmonary edema. , 2010, Progress in cardiovascular diseases.
[127] S. Colan,et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[128] M. Weijerman,et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome , 2010, European Journal of Pediatrics.
[129] C. Panagiotopoulos,et al. Primary Pulmonary Arterial Hypertension and Autoimmune Polyendocrine Syndrome in a Pediatric Patient , 2010, Pediatric Cardiology.
[130] I. Schulze-Neick,et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study , 2010, Heart.
[131] R. Barst,et al. Vasodilator Testing with Nitric Oxide and/or Oxygen in Pediatric Pulmonary Hypertension , 2010, Pediatric Cardiology.
[132] P. Reix,et al. Characteristics of disorders associated with genetic mutations of surfactant protein C , 2010, Archives of Disease in Childhood.
[133] D. Tregouet,et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. , 2010, American journal of respiratory and critical care medicine.
[134] J. Alejos,et al. Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation , 2010, Journal of transplantation.
[135] D. Ivy. Prostacyclin in the intensive care setting. , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[136] T. Humpl,et al. Preoperative pulmonary hemodynamics and assessment of operability: Is there a pulmonary vascular resistance that precludes cardiac operation? , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[137] M. Almodovar,et al. Anesthesia considerations for children with pulmonary hypertension. , 2010, Pediatric Critical Care Medicine.
[138] E. Bae,et al. Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.
[139] Robert I. White,et al. Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome , 2010, American journal of medical genetics. Part A.
[140] G. Raskob,et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. , 2010, Chest.
[141] P. Pellikka,et al. Three-dimensional echocardiographic assessment of right ventricular volume and function in adult patients with congenital heart disease: comparison with magnetic resonance imaging. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[142] J. McGhie,et al. Clinical value of real-time three-dimensional echocardiography for right ventricular quantification in congenital heart disease: validation with cardiac magnetic resonance imaging. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[143] K. Dimopoulos,et al. Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension , 2010, Circulation.
[144] S. Bratton,et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine , 2010, Paediatric anaesthesia.
[145] A. Redington,et al. Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[146] D. O’Regan,et al. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[147] D. Celermajer,et al. Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries , 2010, Pediatric Cardiology.
[148] G. Butrous,et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. , 2009, The Journal of pediatrics.
[149] J. Feinstein,et al. Pulmonary arterial hypertension in children: Diagnostic work-up and challenges. , 2009, Progress in pediatric cardiology.
[150] R. Shemin,et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. , 2009, The Journal of thoracic and cardiovascular surgery.
[151] S. Abman,et al. Towards improving the care of children with pulmonary hypertension: The rationale for developing a Pediatric Pulmonary Hypertension Network. , 2009, Progress in pediatric cardiology.
[152] R. Barst,et al. Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study , 2009, British journal of clinical pharmacology.
[153] M. Gladwin,et al. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. , 2009, Blood.
[154] B. Cowan,et al. Assessments of right ventricular volume and function using three-dimensional echocardiography in older children and adults with congenital heart disease: comparison with cardiac magnetic resonance imaging. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[155] Matthias Gutberlet,et al. Cardiac function by MRI in congenital heart disease: Impact of consensus training on interinstitutional variance , 2009, Journal of magnetic resonance imaging : JMRI.
[156] N. Nakwan,et al. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan , 2009, Acta paediatrica.
[157] P. Khairy,et al. Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study , 2009, Circulation. Cardiovascular interventions.
[158] B. Mulder,et al. Intra-observer and interobserver variability of biventricular function, volumes and mass in patients with congenital heart disease measured by CMR imaging , 2009, The International Journal of Cardiovascular Imaging.
[159] F. Midulla,et al. The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia , 2009, Paediatric anaesthesia.
[160] H. Holtby,et al. Emergency interventional lung assist for pulmonary hypertension. , 2009, Anesthesia and analgesia.
[161] J. Ottenkamp,et al. The effect of bosentan in patients with a failing Fontan circulation , 2009, Cardiology in the Young.
[162] Muhammad Ishaq Khan,et al. Doppler‐defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years , 2009, British journal of haematology.
[163] D. Ivy,et al. Closed-Hub Systems with Protected Connections and the Reduction of Risk of Catheter-Related Bloodstream Infection in Pediatric Patients Receiving Intravenous Prostanoid Therapy for Pulmonary Hypertension , 2009, Infection Control & Hospital Epidemiology.
[164] S. Halpern,et al. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. , 2009, Chest.
[165] A. Lopes,et al. A computer-based matrix for rapid calculation of pulmonary hemodynamic parameters in congenital heart disease , 2009, Annals of thoracic medicine.
[166] E. Heitmiller,et al. Perioperative Management of Children with Obstructive Sleep Apnea , 2009, Anesthesia and analgesia.
[167] M. Nishimura,et al. Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension. , 2009, International heart journal.
[168] Tomas W. Fitzgerald,et al. Genomic and Genic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations , 2009, American journal of human genetics.
[169] B. Brundage,et al. Tadalafil Therapy for Pulmonary Arterial Hypertension , 2009, Circulation.
[170] W. Ravekes,et al. Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[171] T. Humpl,et al. Safety of maximal cardiopulmonary exercise testing in pediatric patients with pulmonary hypertension. , 2009, Chest.
[172] Marc A Simon,et al. Noninvasive Estimation of Pulmonary Vascular Resistance in Pulmonary Hypertension , 2009, Echocardiography.
[173] Binhe Zhou,et al. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery , 2009, Advances in therapy.
[174] M. Corretti,et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. , 2009, American journal of respiratory and critical care medicine.
[175] T. Welte,et al. Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[176] S. Abman. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. , 2009, Annual review of medicine.
[177] M. Humbert,et al. Cardiopulmonary Manifestations of Hepatosplenic Schistosomiasis , 2009, Circulation.
[178] S. Nakatani,et al. Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2009, The American journal of cardiology.
[179] P. Mourani,et al. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. , 2009, The Journal of pediatrics.
[180] N. Rajagopalan,et al. Differential strain and velocity generation along the right ventricular free wall in pulmonary hypertension. , 2009, The Canadian journal of cardiology.
[181] Joseph D. Kay,et al. Sildenafil Increases Systemic Saturation and Reduces Pulmonary Artery Pressure in Patients with Failing Fontan Physiology. , 2009, Congenital heart disease.
[182] M. Humbert,et al. Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia , 2009, Circulation.
[183] R. Matsuoka,et al. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension , 2009, Journal of Medical Genetics.
[184] J. Whitsett,et al. Pulmonary surfactant surface tension influences alveolar capillary shape and oxygenation. , 2009, American journal of respiratory cell and molecular biology.
[185] B. Sibai,et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. , 2009, The New England journal of medicine.
[186] R. Lalonde,et al. Population Pharmacokinetics of Sildenafil in Term Neonates: Evidence of Rapid Maturation of Metabolic Clearance in the Early Postnatal Period , 2009, Clinical pharmacology and therapeutics.
[187] L. Trupin,et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. , 2008, Arthritis and rheumatism.
[188] A. Hager,et al. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. , 2008, European heart journal.
[189] T. Delhaas,et al. Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis. , 2009, The Journal of pediatrics.
[190] V. Soditt,et al. Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn , 1997, Intensive Care Medicine.
[191] R. Ge,et al. Changes of cardiac structure and function in pediatric patients with high altitude pulmonary hypertension in Tibet. , 2009, High altitude medicine & biology.
[192] Michael Jerosch-Herold,et al. Correlation of right ventricular ejection fraction and tricuspid annular plane systolic excursion in tetralogy of Fallot by magnetic resonance imaging , 2009, The International Journal of Cardiovascular Imaging.
[193] K. Mussatto,et al. Correlation of Echocardiographic Markers and Therapy in Persistent Pulmonary Hypertension of the Newborn , 2009, Pediatric Cardiology.
[194] G. Dadlani,et al. Echocardiography in tetralogy of Fallot , 2008, Cardiology in the Young.
[195] D. Kaufman,et al. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.
[196] R. Wiesner,et al. Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[197] A. Doran,et al. Advances in Prostanoid Infusion Therapy for Pulmonary Arterial Hypertension , 2008, Journal of infusion nursing : the official publication of the Infusion Nurses Society.
[198] P. Kirshbom,et al. The bidirectional Glenn operation: a risk factor analysis for morbidity and mortality. , 2008, The Journal of thoracic and cardiovascular surgery.
[199] A. Hislop,et al. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006 , 2008, Heart.
[200] P. Samankatiwat,et al. Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. , 2008, International journal of cardiology.
[201] F. Lacour-Gayet,et al. Outcomes of reparative and transplantation strategies for multilevel left heart obstructions with mitral stenosis. , 2008, The Annals of thoracic surgery.
[202] V. Shah,et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. , 2008, Gastroenterology.
[203] Joseph D. Kay,et al. Performance of Cavopulmonary Palliation at Elevated Altitude: Midterm Outcomes and Risk Factors for Failure , 2008, Circulation.
[204] K. Dimopoulos,et al. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. , 2008, International journal of cardiology.
[205] M. Humbert,et al. Portopulmonary hypertension: survival and prognostic factors. , 2008, American journal of respiratory and critical care medicine.
[206] Robert C. Saunders,et al. What Patients and Their Relatives Think About Testing for BMPR2 , 2008, Journal of Genetic Counseling.
[207] M. Kramer,et al. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: A pilot study , 2008, Respirology.
[208] E. Rosenkranz,et al. Initial experience with the TandemHeart circulatory support system in children. , 2008, ASAIO journal.
[209] K. Maher,et al. Pulmonary Vein Stenosis: Prematurity and Associated Conditions , 2008, Pediatrics.
[210] Michiel M Winter,et al. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[211] C. Canter,et al. Beyond Berlin: heart transplantation in the "untransplantable". , 2008, The Journal of thoracic and cardiovascular surgery.
[212] M. Humbert,et al. Safety Experience With Bosentan in 146 Children 2–11 Years Old With Pulmonary Arterial Hypertension: Results from the European Postmarketing Surveillance Program , 2008, Pediatric Research.
[213] J. Tobias,et al. Preliminary Experience With Nesiritide in Pediatric Patients Less Than 12 Months of Age , 2008, Journal of intensive care medicine.
[214] J. Trotter,et al. Clinical risk factors for portopulmonary hypertension , 2008, Hepatology.
[215] R. Benza,et al. Guidelines for the prevention of central venous catheter‐related blood stream infections with prostanoid therapy for pulmonary arterial hypertension , 2008, International journal of clinical practice. Supplement.
[216] M. Humbert,et al. Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology , 2008, Medicine.
[217] M. Weiss,et al. Comparison of Calculated with Measured Oxygen Consumption in Children Undergoing Cardiac Catheterization , 2008, Pediatric Cardiology.
[218] M. Humbert,et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. , 2008, American journal of respiratory and critical care medicine.
[219] B. Wiens,et al. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 , 2008, Circulation.
[220] P. Engelfriet,et al. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. , 2008, International journal of cardiology.
[221] J. Feinstein,et al. Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[222] J. Knowles,et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[223] Tal Geva,et al. Accuracy of guideline recommendations for two-dimensional quantification of the right ventricle by echocardiography , 2008, The International Journal of Cardiovascular Imaging.
[224] Dionne A. Graham,et al. Matrix-Array 3-Dimensional Echocardiographic Assessment of Volumes, Mass, and Ejection Fraction in Young Pediatric Patients With a Functional Single Ventricle: A Comparison Study With Cardiac Magnetic Resonance , 2008, Circulation.
[225] R. K. Kumar,et al. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[226] Glyn Williams,et al. Anesthetic management of children with pulmonary arterial hypertension , 2008, Paediatric anaesthesia.
[227] M. Humbert,et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases , 2008, European Respiratory Journal.
[228] P. Mourani,et al. Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. , 2008, The Journal of pediatrics.
[229] I. Schulze-Neick,et al. Classifying pulmonary hypertension in the setting of the congenitally malformed heart – cleaning up a dog’s dinner , 2008, Cardiology in the Young.
[230] R. Berger,et al. Pulmonary arterial hypertension in congenital cardiac disease – the need for refinement of the Evian-Venice classification , 2008, Cardiology in the Young.
[231] P. Mourani,et al. Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease , 2008, Pediatrics.
[232] R. Barst,et al. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.
[233] S. Bhargava,et al. Spiral patterns of gold nanoclusters in silicon (100) produced by metal vapour vacuum arc implantation of gold ions , 2008, Nanotechnology.
[234] K. Dohi,et al. Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study , 2008, Postgraduate Medical Journal.
[235] Deni Elliott,et al. Genetic Information Nondiscrimination Act , 2008 .
[236] S. Ge,et al. Accuracy and reproducibility of real-time three-dimensional echocardiography for assessment of right ventricular volumes and ejection fraction in children. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[237] G. Simonneau,et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.
[238] P. Tourneux,et al. Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan , 2008, European Journal of Pediatrics.
[239] D. McElhinney,et al. Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.
[240] T. Binder,et al. A Case of an Alpinist with a Patent Foramen Ovale and High-Altitude Pulmonary Edema at Moderate Altitude , 2007, Wilderness & environmental medicine.
[241] W. Travis,et al. Diffuse lung disease in young children: application of a novel classification scheme. , 2007, American journal of respiratory and critical care medicine.
[242] J. Feinstein,et al. Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation , 2007, Anesthesia and analgesia.
[243] M. Sockrider,et al. Clinical, radiological and pathological features of ABCA3 mutations in children , 2007, Thorax.
[244] J. Belik,et al. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. , 2007, American journal of respiratory and critical care medicine.
[245] C. Shapiro-Mendoza,et al. Differences in mortality between late-preterm and term singleton infants in the United States, 1995-2002. , 2007, The Journal of pediatrics.
[246] J. Rychik,et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. , 2007, The Annals of thoracic surgery.
[247] K. Olmsted,et al. Can inhaled prostacyclin stimulate surfactant in ELBW infants? , 2007, Journal of Perinatology.
[248] S. Takatsuki,et al. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[249] B. Mulder,et al. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? , 2007, American heart journal.
[250] C. Opasich,et al. Intra-observer and interobserver reproducibility of right ventricle volumes, function and mass by cardiac magnetic resonance , 2007, Journal of cardiovascular medicine.
[251] E. Chau,et al. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. , 2007, International journal of cardiology.
[252] R. Pyeritz,et al. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? , 2007, Chest.
[253] T. A. Parker,et al. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. , 2007, The Journal of pediatrics.
[254] S. Schoenberg,et al. MRT der akuten Lungenembolie , 2007, Der Radiologe.
[255] A. Lammers,et al. The 6-minute walk test: normal values for children of 4–11 years of age , 2007, Archives of Disease in Childhood.
[256] F. Pigula,et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. , 2007, The Annals of thoracic surgery.
[257] K. Dimopoulos,et al. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease , 2007, Heart.
[258] S. Abman,et al. Inhaled nitric oxide in the premature newborn. , 2007, The Journal of pediatrics.
[259] A. Hamvas,et al. Genetic Disorders of Surfactant Proteins , 2007, Neonatology.
[260] P. Engelfriet,et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease , 2006, Heart.
[261] A. McEwan,et al. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.
[262] C. M. Cotten,et al. Mechanical ventilation strategies in the management of congenital diaphragmatic hernia. , 2007, Seminars in pediatric surgery.
[263] K. Gauvreau,et al. Variables influencing the accuracy of right ventricular volume assessment by real-time 3-dimensional echocardiography: an in vitro validation study. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[264] C. Mullins,et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. , 2007, American heart journal.
[265] J. Bronzwaer,et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.
[266] K. Gauvreau,et al. Causes of death after congenital heart surgery. , 2007, The Annals of thoracic surgery.
[267] Grzegorz Opolski,et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. , 2007, Chest.
[268] S. Raja,et al. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. , 2007, Journal of cardiothoracic and vascular anesthesia.
[269] S. Lakshminrusimha,et al. Characteristics of pulmonary hypertension in preterm neonates , 2007, Journal of Perinatology.
[270] William A. Dafoe,et al. Principles of Exercise Testing and Interpretation , 2007 .
[271] Rivka L. Shoulson,et al. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006. , 2007, MMWR. Morbidity and mortality weekly report.
[272] R. Friesen,et al. Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.
[273] D. Ivy,et al. Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil. , 2007, The American journal of cardiology.
[274] B. Vohr,et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. , 2007, The Journal of pediatrics.
[275] G. Nuthall,et al. Long-Term Respiratory Support in Children with Giant Omphalocele , 2007, Anaesthesia and intensive care.
[276] M. Gladwin,et al. PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children , 2007, Pediatric hematology and oncology.
[277] S. Schoenberg,et al. [MRI of pulmonary embolism]. , 2007, Der Radiologe.
[278] Richard V. Williams,et al. Assessment of right ventricular size and function: echo versus magnetic resonance imaging. , 2007, Congenital heart disease.
[279] P. Woo,et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. , 2006, Arthritis and rheumatism.
[280] R. Barst,et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil , 2006, European Respiratory Journal.
[281] Orhan Uzun,et al. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. , 2006, The Annals of thoracic surgery.
[282] R. Barst,et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.
[283] I. Seri,et al. Cardiovascular Effects of Sildenafil in Neonates and Infants with Congenital Diaphragmatic Hernia and Pulmonary Hypertension , 2006, Neonatology.
[284] M. Humbert,et al. Genes and Pulmonary Arterial Hypertension , 2006, Respiration.
[285] L. Shekerdemian,et al. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. , 2006, American journal of respiratory and critical care medicine.
[286] Hikoro Matsui,et al. Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome. , 2006, The Journal of thoracic and cardiovascular surgery.
[287] T. Abraham,et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.
[288] M. Gupta,et al. Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome: A Preliminary Observational Study , 2006, Circulation.
[289] W. Seeger,et al. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. , 2006, Journal of the American College of Cardiology.
[290] K. Bloch,et al. Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema , 2006, Annals of Internal Medicine.
[291] D. Barron,et al. Journal of Cardiothoracic Surgery Open Access the Impact of Altitude on Early Outcome following the Fontan Operation , 2022 .
[292] N. Rajagopalan,et al. Right ventricular systolic function is not the sole determinant of tricuspid annular motion. , 2006, The American journal of cardiology.
[293] A. Hamvas,et al. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. , 2006, The Journal of pediatrics.
[294] J. Cogan,et al. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.
[295] M. Beghetti,et al. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan , 2006, European journal of clinical investigation.
[296] M. Humbert,et al. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects , 2006, European journal of clinical investigation.
[297] P. Luciw,et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. , 2006, American journal of respiratory and critical care medicine.
[298] M. Gatzoulis,et al. Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study , 2006, Circulation.
[299] A. Nicholson,et al. Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.
[300] Eric W. Glissmeyer,et al. Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension , 2006, Circulation.
[301] W. Williams,et al. Sudden unexpected death in children with heart disease. , 2006, Congenital heart disease.
[302] R. Steinhorn,et al. Neonatal extracorporeal life support: impact of new therapies on survival. , 2006, The Journal of pediatrics.
[303] T. Medsger,et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. , 2006, The Journal of rheumatology.
[304] A. Torbicki,et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. , 2006, Chest.
[305] M. Humbert,et al. Pulmonary arterial hypertension in France: results from a national registry. , 2006, American journal of respiratory and critical care medicine.
[306] S. Abman,et al. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis‐related lung disease , 2006, Pediatric pulmonology.
[307] R. Weintraub,et al. Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[308] A. Sola,et al. Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study , 2006, Pediatrics.
[309] M. Digilio,et al. Genetic syndromes and outcome after surgical correction of tetralogy of Fallot. , 2006, The Annals of thoracic surgery.
[310] M. Humbert,et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.
[311] P. Dekoninck,et al. Growth of pulmonary microvasculature in ventilated preterm infants. , 2006, American journal of respiratory and critical care medicine.
[312] P. Wouters,et al. Longitudinal but not circumferential deformation reflects global contractile function in the right ventricle with open pericardium. , 2006, American journal of physiology. Heart and circulatory physiology.
[313] J. Eriksson,et al. Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue , 2006, European journal of clinical investigation.
[314] J. Loscalzo,et al. Pulmonary arterial hypertension. , 2004, Annals of medicine.
[315] P Richards,et al. High Altitude Illness , 2011, Journal of the Royal Army Medical Corps.
[316] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[317] T. Fleming,et al. Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.
[318] C. Baufreton,et al. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects. , 2005, Chest.
[319] T. Welte,et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.
[320] Dimitris N. Metaxas,et al. Three-dimensional systolic kinematics of the right ventricle. , 2005, American journal of physiology. Heart and circulatory physiology.
[321] A. Hislop,et al. Response to bosentan in children with pulmonary hypertension , 2005, Heart.
[322] G. Ceneviva,et al. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease , 2005, Pediatric pulmonology.
[323] Steven H Abman,et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.
[324] D. Badesch,et al. Ambrisentan therapy for pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.
[325] J. F. Keane,et al. Current Management of Severe Congenital Mitral Stenosis: Outcomes of Transcatheter and Surgical Therapy in 108 Infants and Children , 2005, Circulation.
[326] U. Fakler,et al. Assumed oxygen consumption frequently results in large errors in the determination of cardiac output. , 2005, The Journal of thoracic and cardiovascular surgery.
[327] C. Fraser,et al. Preterm Infants With Congenital Heart Disease and Bronchopulmonary Dysplasia: Postoperative Course and Outcome After Cardiac Surgery , 2005, Pediatrics.
[328] J. O'connor,et al. Portopulmonary hypertension in pediatric patients. , 2005, The Journal of pediatrics.
[329] D. Stephens,et al. Beneficial Effect of Oral Sildenafil Therapy on Childhood Pulmonary Arterial Hypertension: Twelve-Month Clinical Trial of a Single-Drug, Open-Label, Pilot Study , 2005, Circulation.
[330] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[331] S. Black,et al. Endothelin-1 in Congenital Heart Disease , 2005, Pediatric Research.
[332] A. Magee,et al. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension. , 2005, International journal of cardiology.
[333] M. Leval. The Fontan circulation: a challenge to William Harvey? , 2005, Nature Clinical Practice Cardiovascular Medicine.
[334] D. Ivy,et al. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. , 2005, Seminars in perinatology.
[335] D. Ivy,et al. Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension. , 2005, The American journal of cardiology.
[336] J. Cogan,et al. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension , 2005, Genetics in Medicine.
[337] J. F. Keane,et al. Left Heart Growth, Function, and Reintervention After Balloon Aortic Valvuloplasty for Neonatal Aortic Stenosis , 2005, Circulation.
[338] M. Gatzoulis,et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. , 2005, International journal of cardiology.
[339] J. Moller,et al. The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect , 1982, Pediatric Cardiology.
[340] W. Williams,et al. Conventional and sutureless techniques for management of the pulmonary veins: Evolution of indications from postrepair pulmonary vein stenosis to primary pulmonary vein anomalies. , 2005, The Journal of thoracic and cardiovascular surgery.
[341] N. Sandoval,et al. Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. , 2005, The Annals of thoracic surgery.
[342] M. Blayney,et al. Elevated Carbon Dioxide Tension as a Predictor of Subsequent Adverse Events in Infants with Bronchopulmonary Dysplasia , 2005, Lung.
[343] C. Warnes. Pregnancy and pulmonary hypertension. , 2004, International journal of cardiology.
[344] R. Wolfe,et al. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude. , 2004, Archives of pediatrics & adolescent medicine.
[345] M. Stefadouros,et al. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. , 2004, The Journal of heart valve disease.
[346] D. Ivy,et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. , 2004, The Journal of thoracic and cardiovascular surgery.
[347] C. Appleton,et al. Noninvasive assessment of right atrial pressure using Doppler tissue imaging. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[348] B. Bejjani,et al. Expanding the phenotype of alveolar capillary dysplasia (ACD). , 2004, The Journal of pediatrics.
[349] P. Mourani,et al. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. , 2004, American journal of respiratory and critical care medicine.
[350] R. Rodríguez-Roisín,et al. Pulmonary–Hepatic vascular Disorders (PHD) , 2004, European Respiratory Journal.
[351] S. Shankaran,et al. Aerosolized PGE1: A Selective Pulmonary Vasodilator in Neonatal Hypoxemic Respiratory Failure Results of a Phase I/II Open Label Clinical Trial , 2004, Pediatric Research.
[352] S. Takamoto,et al. Hypoplasia of the Small Pulmonary Arteries in Hypoplastic Left Heart Syndrome With Restrictive Atrial Septal Defect , 2004, Circulation.
[353] M. Gladwin,et al. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator , 2004, Nature Medicine.
[354] J. Knowles,et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease , 2004, European Respiratory Journal.
[355] G. Maislin,et al. Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension , 2004, Circulation.
[356] W. Seeger,et al. Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp , 2004, Annals of Internal Medicine.
[357] T. Hunt,et al. Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers , 2004, Journal of cardiovascular pharmacology.
[358] I. Anand,et al. Syndromes of subacute mountain sickness. , 2004, High altitude medicine & biology.
[359] D. Mccrory,et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[360] A. Torbicki,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[361] M. Humbert,et al. Pathologic assessment of vasculopathies in pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[362] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[363] J. Lock,et al. Hypoplastic Left Heart Syndrome With Intact or Highly Restrictive Atrial Septum: Outcome After Neonatal Transcatheter Atrial Septostomy , 2004, Circulation.
[364] S. Black,et al. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs* , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[365] M. Schluchter,et al. The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[366] M. Humbert,et al. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension , 2004, Thorax.
[367] D. Ivy,et al. Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan. , 2004, The American journal of cardiology.
[368] Tal Geva,et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.
[369] J. Hellmann,et al. Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn , 2004, Journal of perinatal medicine.
[370] A. Rustgi,et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) , 2004, The Lancet.
[371] S. Hamrick,et al. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[372] P. Dillon,et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. , 2004, Journal of pediatric surgery.
[373] J. Benson,et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[374] M. Beghetti. Congenital heart disease and pulmonary hypertension. , 2004, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[375] James C Moon,et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. , 2004, American heart journal.
[376] R. Redberg. Coronary artery calcium and cardiac events. , 2003, Circulation.
[377] F. Reichenberger,et al. Atrial septostomy in the treatment of severe pulmonary arterial hypertension , 2003, Thorax.
[378] U. Ozbek,et al. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine. , 2003, Journal of cardiothoracic and vascular anesthesia.
[379] J. A. Powers,et al. Cardiopulmonary effects of nebulized sodium nitroprusside in term infants with hypoxic respiratory failure. , 2003, The Journal of pediatrics.
[380] S. Bratton,et al. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. , 2003, The Annals of thoracic surgery.
[381] S. Archer,et al. Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension , 2003, Circulation.
[382] O. Hallioglu,et al. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. , 2003, The American journal of cardiology.
[383] C. Brizard,et al. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery , 2003, Intensive Care Medicine.
[384] K. Brown,et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. , 2003, The New England journal of medicine.
[385] G. Butrous,et al. Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease , 2003, Circulation.
[386] A. Torbicki,et al. Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension , 2003, Circulation.
[387] E. Swenson,et al. High altitude pulmonary oedema. , 2003, Swiss medical weekly.
[388] W. Seeger,et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[389] J. Deanfield,et al. Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation , 2003, Circulation.
[390] K. Wasserman,et al. Beraprost therapy for pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[391] G. Koch,et al. Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension. , 2003, The American journal of cardiology.
[392] A. Redington,et al. Measured versus estimated oxygen consumption in ventilated patients with congenital heart disease: The validity of predictive equations , 2003, Critical care medicine.
[393] D. Ivy,et al. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. , 2003, The Journal of pediatrics.
[394] R. Barst,et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension , 2003, Clinical pharmacology and therapeutics.
[395] C. Appleton,et al. A simple method for noninvasive estimation of pulmonary vascular resistance. , 2003, Journal of the American College of Cardiology.
[396] J. Newman,et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. , 2003, American journal of respiratory and critical care medicine.
[397] M. Sutton,et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.
[398] A. Cohen-Solal,et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study , 2003, Hepatology.
[399] Claude D Martin,et al. High-altitude pulmonary edema at moderate altitude (< 2,400 m; 7,870 feet): a series of 52 patients. , 2003, Chest.
[400] C. Carroll,et al. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. , 2002, The Journal of pediatrics.
[401] J. Farber. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. , 2002, Pediatrics.
[402] J. Farber,et al. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. , 2002, Pediatrics.
[403] J. Reveille,et al. Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases. , 2002, Arthritis and rheumatism.
[404] R. Favaloro,et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[405] D. Ivy,et al. Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): The INOP Test Study Group , 2002, Circulation.
[406] W. Seeger,et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial , 2002, The Lancet.
[407] A. Atz,et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. , 2002, The Journal of thoracic and cardiovascular surgery.
[408] S. Hodge,et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives , 2002, European Respiratory Journal.
[409] W. Seeger,et al. Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.
[410] Sanjay Kumar. Indian doctor in protest after using Viagra to save “blue babies” , 2002, BMJ : British Medical Journal.
[411] J. Stamler,et al. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn , 2002, The Lancet.
[412] S. Abman. Monitoring cardiovascular function in infants with chronic lung disease of prematurity , 2002, Archives of disease in childhood. Fetal and neonatal edition.
[413] C. Jonmarker,et al. How common is severe pulmonary hypertension after pediatric cardiac surgery? , 2002, The Journal of thoracic and cardiovascular surgery.
[414] M. Uematsu,et al. Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[415] M. Humbert,et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. , 2002, Journal of the American College of Cardiology.
[416] K. Kawazoe,et al. Can Synthetic Aperture Magnetometry Images on Magnetocardiography Identify the Space Locations of Myocardial Viability , 2002 .
[417] R. Barst,et al. Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.
[418] Takahiro Iwami,et al. The usefulness of a 10% air-10% blood-80% saline mixture for contrast echocardiography: Doppler measurement of pulmonary artery systolic pressure. , 2002, Journal of the American College of Cardiology.
[419] D. Tibboel,et al. Late versus early surgical correction for congenital diaphragmatic hernia in newborn infants. , 2000, The Cochrane database of systematic reviews.
[420] Tianyi Wu,et al. High altitude heart disease in children in Tibet. , 2002, High altitude medicine & biology.
[421] S. Ricksten,et al. The Additive Pulmonary Vasodilatory Effects of Inhaled Prostacyclin and Inhaled Milrinone in Postcardiac Surgical Patients with Pulmonary Hypertension , 2001, Anesthesia and analgesia.
[422] S. Abman. Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.
[423] J. Sandoval,et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. , 2001, American journal of respiratory and critical care medicine.
[424] M. Berner,et al. Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion , 2001, Heart.
[425] M. Humbert,et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.
[426] A. Durmowicz. Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. , 2001, Pediatrics.
[427] T. Saji,et al. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[428] P. Giannuzzi,et al. Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure. , 2001, Journal of the American College of Cardiology.
[429] C. Sartori,et al. High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure , 2001, Circulation.
[430] M. Davies,et al. Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. , 2001, The Cochrane database of systematic reviews.
[431] A. Pigna,et al. High-frequency oscillatory ventilation versus conventional mechanical ventilation in congenital diaphragmatic hernia. , 2001, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[432] A. Kalangos,et al. Inhaled Nitric Oxide Versus Aerosolized Iloprost in Secondary Pulmonary Hypertension in Children With Congenital Heart Disease: Vasodilator Capacity and Cellular Mechanisms , 2001, Circulation.
[433] W. Williams,et al. Critical aortic stenosis in the neonate: a multi-institutional study of management, outcomes, and risk factors. Congenital Heart Surgeons Society. , 2001, The Journal of thoracic and cardiovascular surgery.
[434] M. Yaron,et al. Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001. , 2001, High altitude medicine & biology.
[435] M. Gatzoulis,et al. Sildenafil in primary pulmonary hypertension. , 2000, The New England journal of medicine.
[436] A. Keech,et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study , 2000, The Lancet.
[437] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[438] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[439] F. Hanley,et al. Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: Associated complications and outcomes , 2000, Critical care medicine.
[440] M. Beghetti,et al. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease , 2000, Critical care medicine.
[441] A. Magee,et al. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension , 2000, Heart.
[442] J. Laffey,et al. Injurious effects of hypocapnic alkalosis in the isolated lung. , 2000, American journal of respiratory and critical care medicine.
[443] J. Hawkins,et al. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. , 2000, The Annals of thoracic surgery.
[444] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[445] N. Shaw,et al. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease , 2000, Archives of disease in childhood. Fetal and neonatal edition.
[446] C. Wren,et al. Sudden death in children and adolescents , 2000, Heart.
[447] B Wranne,et al. Normal regional right ventricular function and its change with age: a Doppler myocardial imaging study. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[448] M. Keszler,et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.
[449] J. Tyson,et al. Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes , 2000, Pediatrics.
[450] K. Tabayashi,et al. Pulmonary vascular changes induced by congenital obstruction of pulmonary venous return. , 2000, The Annals of thoracic surgery.
[451] R A Nishimura,et al. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. , 2000, Mayo Clinic proceedings.
[452] M. Quiñones,et al. Estimation of mean right atrial pressure using tissue Doppler imaging. , 1999, The American journal of cardiology.
[453] S. Black,et al. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. , 1999, American journal of physiology. Heart and circulatory physiology.
[454] D. Ivy,et al. Congenital pulmonary venous stenosis presenting as persistent pulmonary hypertension of the newborn , 1999, Pediatric pulmonology.
[455] S. Rich,et al. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. , 1999, Journal of the American College of Cardiology.
[456] D. Cornfield,et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial , 1999, The Lancet.
[457] M. Sklansky,et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. , 1999, The American journal of cardiology.
[458] Geoffrey I. Webb,et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. , 1999, The American journal of cardiology.
[459] M. Uematsu,et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[460] J. Kattwinkel,et al. Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn , 1999, Pediatrics.
[461] J. Hohlfeld,et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[462] J. Rychik,et al. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. , 1999, Journal of the American College of Cardiology.
[463] J. Child,et al. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. , 1999, Journal of the American College of Cardiology.
[464] P. Lange,et al. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects , 1999, Heart.
[465] A. Atz,et al. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. , 1999, Anesthesiology.
[466] D. Badesch,et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[467] R. Barst,et al. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. , 1999, Circulation.
[468] J. Rychik,et al. Pulmonary Hypertension in Children following Extracorporeal Membrane Oxygenation Therapy and Repair of Congenital Diaphragmatic Hernia , 1999, Journal of Perinatology.
[469] G. Maislin,et al. Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.
[470] J. Roos‐Hesselink,et al. [Eisenmenger syndrome in adults]. , 1999, Nederlands tijdschrift voor geneeskunde.
[471] J. Lock,et al. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. , 1999, Journal of the American College of Cardiology.
[472] J. Rychik,et al. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. , 1999, Pediatrics.
[473] T. Krummel,et al. Postnatal pulmonary hypertension after repair of congenital diaphragmatic hernia: predicting risk and outcome. , 1999, Journal of pediatric surgery.
[474] B. Levine,et al. The role of the right ventricle during hypobaric hypoxic exercise: insights from patients after the Fontan operation. , 1999, Medicine and science in sports and exercise.
[475] M. Gorenflo,et al. Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease , 1999, Clinical chemistry and laboratory medicine.
[476] J. Räsänen,et al. Measured versus predicted oxygen consumption in children with congenital heart disease , 1998, Heart.
[477] P. Presbitero,et al. Eisenmenger syndrome. Factors relating to deterioration and death. , 1998, European heart journal.
[478] M. Humbert,et al. High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease. , 1998, AJR. American journal of roentgenology.
[479] S. Rybalkin,et al. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[480] S. Rich,et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. , 1998, Chest.
[481] J. Sandoval,et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. , 1998, Journal of the American College of Cardiology.
[482] S. Colan,et al. Evaluation of regional differences in right ventricular systolic function by acoustic quantification echocardiography and cine magnetic resonance imaging. , 1998, Circulation.
[483] N. Silverman,et al. The Effects of Inhaled Nitric Oxide on Postoperative Pulmonary Hypertension in Infants and Children Undergoing Surgical Repair of Congenital Heart Disease , 1998, Anesthesia and analgesia.
[484] D. Ivy,et al. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. , 1998, The Journal of thoracic and cardiovascular surgery.
[485] J. Chanda,et al. Pulmonary artery banding in Eisenmenger complex. , 1998, The Journal of thoracic and cardiovascular surgery.
[486] D. Fassbender,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: identification of the target vessel by myocardial contrast echocardiography , 1998 .
[487] D. Bulas,et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. , 1998, The Journal of pediatrics.
[488] C. White,et al. Pulmonary capillary hemangiomatosis: radiographic appearance. , 1998, Journal of thoracic imaging.
[489] S. Kuribayashi,et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.
[490] J Burnett,et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. , 1997, The Journal of thoracic and cardiovascular surgery.
[491] S. Colan,et al. Functional outcome after the Fontan operation: factors influencing late morbidity. , 1997, The Journal of thoracic and cardiovascular surgery.
[492] H P Gurtner,et al. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. , 1997, Chest.
[493] N Hosten,et al. Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass. , 1997, Heart.
[494] G. Redding,et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn , 1997 .
[495] C. Knauer,et al. Cardiopulmonary manifestations of schistosomiasis. , 1997, Seminars in respiratory infections.
[496] J. Reeves,et al. Inflammatory processes may predispose children to high-altitude pulmonary edema. , 1997, The Journal of pediatrics.
[497] J. F. Keane,et al. Clinical course and hemodynamic observations after supraannular mitral valve replacement in infants and children. , 1997, Journal of the American College of Cardiology.
[498] J. Vacanti,et al. Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. , 1997, Journal of pediatric surgery.
[499] Jesse D. Roberts,et al. Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .
[500] Cook,et al. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. , 1997, The New England journal of medicine.
[501] D. Ivy,et al. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia. , 1997, American journal of respiratory and critical care medicine.
[502] R. Polin,et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. , 1997, The New England journal of medicine.
[503] Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). , 1997, Pediatrics.
[504] A. Atz,et al. Rebound pulmonary hypertension after inhalation of nitric oxide. , 1996, The Annals of thoracic surgery.
[505] M. Turrentine,et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. , 1996, The Journal of thoracic and cardiovascular surgery.
[506] L. Goldman,et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, JAMA.
[507] T. Saji,et al. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension. , 1996, The American journal of cardiology.
[508] Duncan Macrae,et al. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation , 1996, The Lancet.
[509] S. Nagueh,et al. Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function. , 1996, Circulation.
[510] P. Davis,et al. Principles of Exercise Testing and Interpretation , 1996 .
[511] J. Collazos,et al. Acute, reversible pulmonary hypertension associated with cocaine use. , 1996, Respiratory medicine.
[512] M. Berner,et al. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. , 1996, The American journal of cardiology.
[513] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[514] R. Jonas,et al. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. , 1996, The American journal of cardiology.
[515] F. Walther,et al. Surfactant replacement therapy for meconium aspiration syndrome. , 1996, Pediatrics.
[516] K. Morris,et al. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. , 1996, The Journal of clinical investigation.
[517] C. White,et al. Pulmonary vascular disorders masquerading as interstitial lung disease , 1995, Pediatric pulmonology.
[518] A. Atz,et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. , 1995, Critical care medicine.
[519] A. Redington,et al. In vitro validation of right ventricular volume measurement by three dimensional echocardiography. , 1995, British heart journal.
[520] A. C. Bryan,et al. Increased respiratory system resistance and bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[521] J. Reiber,et al. Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. , 1995, The American journal of cardiology.
[522] D. Ivy,et al. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. , 1995, The American journal of physiology.
[523] V. Damjanović,et al. Coagulase-negative staphylococcal sepsis in preterm neonates , 1995, The Lancet.
[524] T. Foroud,et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[525] J. Gaynor,et al. Late outcome of survivors of intervention for neonatal aortic valve stenosis. , 1995, The Annals of thoracic surgery.
[526] A. Keech,et al. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide , 1995, The Lancet.
[527] S. Perry,et al. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. , 1995, Journal of the American College of Cardiology.
[528] S. Abman,et al. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. , 1995, The Journal of pediatrics.
[529] S. Kaplan,et al. Factors influencing survival in patients undergoing the bidirectional Glenn anastomosis. , 1995, The American journal of cardiology.
[530] W. Gersony,et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. , 1995, Circulation.
[531] D. Houssin,et al. Pulmonary arteriovenous shunting in children with liver disease. , 1995, The Journal of pediatrics.
[532] M. Berner,et al. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. , 1995, British heart journal.
[533] G. Pearson,et al. Extracorporeal membrane oxygenation and the treatment of critical pulmonary hypertension in congenital heart disease. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[534] J. Loscalzo,et al. Cardiovascular Effects of Inhaled Nitric Oxide in Patients With Left Ventricular Dysfunction , 1994, Circulation.
[535] H. Fahnenstich,et al. Aerosolised prostacyclin for pulmonary hypertension in neonates. , 1994, Archives of disease in childhood. Fetal and neonatal edition.
[536] R. Barst,et al. Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin , 1994, Annals of Internal Medicine.
[537] H. Mohri,et al. Late results after correction of ventricular septal defect with severe pulmonary hypertension. , 1994, The Tohoku journal of experimental medicine.
[538] F. Pileggi,et al. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. , 1994, The American journal of cardiology.
[539] P. Hickey,et al. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension , 1994, Critical care medicine.
[540] S. Abman,et al. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. , 1994, The Journal of pediatrics.
[541] P. Cagle,et al. Pulmonary histopathology in cocaine abusers. , 1994, Human pathology.
[542] D. Doty,et al. Early and intermediate results of the Fontan procedure at moderately high altitude. , 1994, The Annals of thoracic surgery.
[543] D. Tibboel,et al. Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: incidence and vasodilator therapy. , 1993, Journal of pediatric surgery.
[544] J. Ritter,et al. Thromboxane A2 and Prostacyclin Biosynthesis in Children and Adolescents With Pulmonary Vascular Disease , 1993, Circulation.
[545] R. Freedom,et al. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. , 1993, British heart journal.
[546] D. Wessel,et al. Use of Inhaled Nitric Oxide and Acetlcholine in the Evaluation of Pulmonary Hypertension and Endothelial Function After Cardiopulmonary Bypass , 1993, Circulation.
[547] P. Lönnqvist,et al. Near fatal pulmonary hypertension after surgical repair of congenital diaphragmatic hernia , 1993, Anaesthesia.
[548] J. Skinner,et al. Right heart pressure determination by Doppler in infants with tricuspid regurgitation. , 1993, Archives of disease in childhood.
[549] S. Colan,et al. Individual pulmonary vein size and survival in infants with totally anomalous pulmonary venous connection. , 1993, Journal of the American College of Cardiology.
[550] E. Shaffer,et al. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. , 1993, The Journal of pediatrics.
[551] S. Abman,et al. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. , 1993, The Journal of pediatrics.
[552] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[553] G. Brévière,et al. "Infantile" form of the scimitar syndrome with pulmonary hypertension. , 1993, The American journal of cardiology.
[554] O. Hess,et al. Left ventricular diastolic dysfunction late after coarctation repair in childhood: influence of left ventricular hypertrophy. , 1993, Journal of the American College of Cardiology.
[555] A. Marelli,et al. Risk of Stroke in Adults With Cyanotic Congenital Heart Disease , 1993, Circulation.
[556] S Dohi,et al. Errors in the measurement of cardiac output by thermodilution , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[557] R. R. Wolfe,et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. , 1993, Circulation.
[558] L. Wilkins. Early Effects of Tissue‐Type Plasminogen Activator Added to Conventional Therapy on the Culprit Coronary Lesion in Patients Presenting With Ischemic Cardiac Pain at Rest Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trialx , 1993, Circulation.
[559] B. Groves,et al. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. , 1993, Journal of applied physiology.
[560] J. Alpert,et al. Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. , 1993, American heart journal.
[561] V. Menashe,et al. Total anomalous pulmonary venous connection in neonates and young infants: repair in the current era. , 1993, The Annals of thoracic surgery.
[562] P. Vouhé,et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects , 1992, The Lancet.
[563] H. Mohri,et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. , 1992, The Journal of thoracic and cardiovascular surgery.
[564] Y. Nakamura,et al. Comparison of thermodilution and Fick methods for measurement of cardiac output in tricuspid regurgitation. , 1992, The American journal of cardiology.
[565] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[566] S. Khuri,et al. Cause and impact of pulmonary hypertension in isolated aortic stenosis on operative mortality for aortic valve replacement in men. , 1992, The American journal of cardiology.
[567] M. Erkinjuntti,et al. Sleep apnea syndrome in children--secondary to adenotonsillar hypertrophy? , 1992, Acta oto-laryngologica. Supplementum.
[568] J. Moller,et al. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. , 1991, The American journal of cardiology.
[569] P. Vock,et al. Prevention of high-altitude pulmonary edema by nifedipine. , 1991, The New England journal of medicine.
[570] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[571] N. Evans,et al. Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease. , 1991, Archives of disease in childhood.
[572] G. Amidon,et al. Pharmacokinetics and Pharmacodynamics of Nifedipine in Children with Bronchopulmonary Dysplasia and Pulmonary Hypertension , 1991, Pediatric Research.
[573] R. Hopkins,et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[574] N. Schiller,et al. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.
[575] A. Hislop,et al. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease , 1990, Pediatric pulmonology.
[576] N. Reichek,et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. , 1989, Circulation.
[577] L. Hillis,et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.
[578] C W White,et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. , 1989, The New England journal of medicine.
[579] J. S. Weinstein,et al. Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. , 1989, Circulation.
[580] P. Clarkson,et al. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. , 1989, The American journal of cardiology.
[581] A. Stecenko,et al. Predicting arterial oxygen tension from maximum expiratory flow volume curves in cystic fibrosis , 1989, Pediatric pulmonology.
[582] B. Byrd,et al. Saline contrast enhancement of trivial Doppler tricuspid regurgitation signals for estimating pulmonary artery pressure. , 1988, The American journal of cardiology.
[583] A. Rosenthal,et al. Acute Hemodynamic Effects of Nifedipine in Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension , 1988, Pediatric Research.
[584] J. Rouleau,et al. Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. , 1988, Annals of internal medicine.
[585] G. J. Sui,et al. Subacute infantile mountain sickness , 1988, The Journal of pathology.
[586] B. Corrin,et al. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. , 1988, British heart journal.
[587] N. Schiller,et al. Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. , 1988, Journal of the American College of Cardiology.
[588] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[589] A. Tal,et al. Ventricular dysfunction in children with obstructive sleep apnea: Radionuclide assessment , 1988, Pediatric pulmonology.
[590] D. G. Ritter,et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. , 1987, Circulation.
[591] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[592] D J Hagler,et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. , 1987, Journal of the American College of Cardiology.
[593] M. Yacoub,et al. Lung biopsy findings in transposition of the great arteries with ventricular septal defect: potentially reversible pulmonary vascular disease is not always synonymous with operability. , 1987, Journal of the American College of Cardiology.
[594] K. Anand,et al. RANDOMISED TRIAL OF FENTANYL ANAESTHESIA IN PRETERM BABIES UNDERGOING SURGERY: EFFECTS ON THE STRESS RESPONSE , 1987, The Lancet.
[595] Z. Huang. [Pulmonary arterial hypertension in portal hypertension]. , 1987, Zhonghua nei ke za zhi.
[596] S. Haworth. Pulmonary vascular bed in children with complete atrioventricular septal defect: relation between structural and hemodynamic abnormalities. , 1986, The American journal of cardiology.
[597] R. Barst. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. , 1986, Chest.
[598] A. Sophocles. High-altitude pulmonary edema in Vail, Colorado, 1975-1982. , 1986, The Western journal of medicine.
[599] R. Wolfe,et al. Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema. , 1985, Circulation.
[600] M. Winniford,et al. Analysis of factors affecting the variability of Fick versus indicator dilution measurements of cardiac output. , 1985, The American journal of cardiology.
[601] J. Seward,et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.
[602] S. Hiraishi,et al. Two-dimensional echocardiographic determinants of interventricular septal configurations in right or left ventricular overload. , 1985, American heart journal.
[603] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[604] R. Jonas,et al. Pulmonary and Systemic Hemodynamic Responses to Fentanyl in Infants , 1985, Anesthesia and analgesia.
[605] M. J. Conley,et al. An echocardiographic index for separation of right ventricular volume and pressure overload. , 1985, Journal of the American College of Cardiology.
[606] R. Wolfe,et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. , 1985, Pediatrics.
[607] J. Siebert,et al. Left ventricular hypoplasia in congenital diaphragmatic hernia. , 1984, Journal of pediatric surgery.
[608] N. Silverman,et al. Comparison of M-mode echocardiographic measurement of right ventricular wall thickness obtained by the subcostal and parasternal approach in children. , 1984, The American journal of cardiology.
[609] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[610] P. Yock,et al. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.
[611] C. Wagenvoort,et al. Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery. , 1984, The Journal of thoracic and cardiovascular surgery.
[612] J. F. Keane,et al. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. , 1984, Circulation.
[613] S. Kaul,et al. Assessment of right ventricular function using two-dimensional echocardiography. , 1984, American heart journal.
[614] T. Pryor,et al. Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function. , 1984, The American journal of cardiology.
[615] G. Hutchins,et al. Primary pulmonary hypertension and cirrhosis: are they related? , 2015, The American review of respiratory disease.
[616] B. Groves,et al. Thermodilution method overestimates low cardiac output in humans. , 1983, The American journal of physiology.
[617] M. Hori,et al. ECHOCARDIOGRAPHV-DOPPLER Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique , 2005 .
[618] A. Weyman,et al. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. , 1982, Circulation.
[619] W. Thurlbeck,et al. Pulmonary hypoplasia in Down's syndrome. , 1982, The New England journal of medicine.
[620] T. Rowland,et al. Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome. , 1981, American journal of diseases of children.
[621] F. Askin,et al. Congenital alveolar capillary dysplasia--an unusual cause of respiratory distress in the newborn. , 1981, American journal of clinical pathology.
[622] A. Wilkinson,et al. Electrocardiographic signs of pulmonary hypertension in children who snore. , 1981, British medical journal.
[623] G. Vlahakes,et al. The Pathophysiology of Failure in Acute Right Ventricular Hypertension: Hemodynamic and Biochemical Correlations , 1981, Circulation.
[624] P. Hackett,et al. High-altitude pulmonary edema in persons without the right pulmonary artery. , 1980, The New England journal of medicine.
[625] J. Fouron,et al. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. , 1980, Pediatrics.
[626] J. Jarmakani,et al. Diagnosis and management of postoperative pulmonary hypertensive crisis. , 1979, Circulation.
[627] J. Philips,et al. USE OF PROSTACYCLIN IN PERSISTENT FETAL CIRCULATION , 1979, The Lancet.
[628] A. Weinberg,et al. Hemodynamic, Pulmonary Vascular, and Myocardial Abnormalities Secondary to Pharmacologic Constriction of the Fetal Ductus Arteriosus: A Possible Mechanism for Persistent Pulmonary Hypertension and Transient Tricuspid Insufficiency in the Newborn Infant , 1979, Circulation.
[629] F. Macartney,et al. Surgical treatment of ventricular septal defect in infancy. Primary repair versus banding of pulmonary artery and later repair. , 1979, British heart journal.
[630] J. Tyson,et al. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. , 1978, The Journal of pediatrics.
[631] J. Reeves,et al. High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. , 1977, The New England journal of medicine.
[632] W. Gersony,et al. Clinical course in ventricular septal defect. , 1977, Circulation.
[633] H. Katsume,et al. Echocardiographic Measurement of Right Ventricular Wall Thickness A New Application of Subxiphoid Echocardiography , 1977, Circulation.
[634] L. Reid,et al. Quantitative structural study of pulmonary circulation in the newborn with pulmonary atresia. , 1977, Thorax.
[635] T. Furuse,et al. Echocardiographic features of primary pulmonary hypertension. , 1976, Yonago acta medica.
[636] E. Blackstone,et al. Optimal age and results in repair of large ventricular septal defects , 1976 .
[637] J. Whittembury,et al. Age as a cause of chronic mountain sickness (Monge's disease) , 1975, International journal of biometeorology.
[638] W. Zingg,et al. Hemodynamic and pulmonary changes following surgical creation of a diaphragmatic hernia in fetal lambs. , 1972, Surgery.
[639] L. Hartley,et al. Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High‐Altitude Pulmonary Edema , 1971, Circulation.
[640] F. Fontan,et al. Surgical repair of tricuspid atresia , 1971, Thorax.
[641] J. Vogel,et al. Hemodynamics in congenital mitral stenosis. , 1971, Chest.
[642] J. Vogel,et al. Role of hypoxia in determining pulmonary vascular resistance in infants with ventricular septal defects. , 1967, American Journal of Cardiology.
[643] G. Khoury,et al. Atrial septal defect associated with pulmonary hypertension in children living at high altitude. , 1967, The Journal of pediatrics.
[644] A. Rudolph,et al. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. , 1966, The Journal of clinical investigation.
[645] N. Banchero,et al. Pulmonary Pressure, Cardiac Output, and Arterial Oxygen Saturation during Exercise at High Altitude and at Sea Level , 1966, Circulation.
[646] A. Fishman,et al. PULMONARY HYPERTENSION AND COR PULMONALE IN CYSTIC FIBROSIS OF THE PANCREAS. , 1964, The Journal of pediatrics.
[647] H. Hultgren,et al. Physiologic Studies of Pulmonary Edema at High Altitude , 1964, Circulation.
[648] G. Khoury,et al. Primary pulmonary hypertension in children living at high altitude. , 1963, The Journal of pediatrics.
[649] L. Cobb,et al. Interaction of chronic hypoxia of moderate altitude on pulmonary hypertension complicating defect of the atrial septum. , 1962, The New England journal of medicine.
[650] J. F. Dammann,et al. The regression of pulmonary vascular disease after the creation of pulmonary stenosis. , 1961, The Journal of thoracic and cardiovascular surgery.
[651] P. Salisbury. Coronary Artery Pressure and Strength of Right Ventricular Contraction , 1955, Circulation research.
[652] D. Dresdale,et al. Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. , 1954, Bulletin of the New York Academy of Medicine.
[653] E. Craige,et al. Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. , 1951, A.M.A. archives of pathology.